Roche Perjeta Breast Cancer Results ASCO: More Disappointment

Bookmark
(Bloomberg Gadfly) -- Roche Holding AG has been a dominant cancer-drug maker for years, meaning the annual meeting of the American Society for Clinical Oncology (ASCO) is usually a showcase for it. 
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.